Claudio Isella

机构：Candiolo Cancer Institute, Istituti di Ricovero e Cura a Carattere Scientifico, University of Turin · ORCID：0000-0003-0679-4756

发表论文 295 篇 · 总被引 5528 次 · h-index 35

代表论文

• Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer (2024 · Nature Genetics · 被引 56)
• Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification (2024 · Molecular Therapy · 被引 29)
• Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity (2023 · Genome Medicine · 被引 19)
• Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 17)
• Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas (2023 · Cell Reports · 被引 12)
• Dual VEGFA / BRAF targeting boosts PD ‐1 blockade in melanoma through GM‐CSF ‐mediated infiltration of M1 macrophages (2023 · Molecular Oncology · 被引 11)